» Articles » PMID: 19468344

Hereditary and Sporadic Forms of Abeta-cerebrovascular Amyloidosis and Relevant Transgenic Mouse Models

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2009 May 27
PMID 19468344
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral amyloid angiopathy (CAA) refers to the specific deposition of amyloid fibrils in the leptomeningeal and cerebral blood vessel walls, often causing secondary vascular degenerative changes. Although many kinds of peptides are known to be deposited as vascular amyloid, amyloid-beta (Abeta)-CAA is the most common type associated with normal aging, sporadic CAA, Alzheimer's disease (AD) and Down's syndrome. Moreover, Abeta-CAA is also associated with rare hereditary cerebrovascular amyloidosis due to mutations within the Abeta domain of the amyloid precursor protein (APP) such as Dutch and Flemish APP mutations. Genetics and clinicopathological studies on these familial diseases as well as sporadic conditions have already shown that CAA not only causes haemorrhagic and ischemic strokes, but also leads to progressive dementia. Transgenic mouse models based on familial AD mutations have also successfully reproduced many of the features found in human disease, providing us with important insights into the pathogenesis of CAA. Importantly, such studies have pointed out that specific vastopic Abeta variants or an unaltered Abeta42/Abeta40 ratio favor vascular Abeta deposition over parenchymal plaques, but higher than critical levels of Abeta40 are also observed to be anti-amyloidogenic. These data would be important in the development of therapies targeting amyloid in vessels.

Citing Articles

An electrostatic cluster guides Aβ40 fibril formation in sporadic and Dutch-type cerebral amyloid angiopathy.

Fu Z, Crooks E, Irizarry B, Zhu X, Chowdhury S, Van Nostrand W J Struct Biol. 2024; 216(2):108092.

PMID: 38615725 PMC: 11162928. DOI: 10.1016/j.jsb.2024.108092.


Fractal Analysis in Neurodegenerative Diseases.

Pirici D, Mogoanta L, Ion D, Kumar-Singh S Adv Neurobiol. 2024; 36:365-384.

PMID: 38468042 DOI: 10.1007/978-3-031-47606-8_18.


Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.

Rajpoot J, Crooks E, Irizarry B, Amundson A, Van Nostrand W, Smith S Biochemistry. 2022; 61(12):1181-1198.

PMID: 35666749 PMC: 9219409. DOI: 10.1021/acs.biochem.1c00781.


Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.

Levin J, Voglein J, Quiroz Y, Bateman R, Ghisays V, Lopera F Alzheimers Dement. 2022; 18(12):2687-2698.

PMID: 35212149 PMC: 9399299. DOI: 10.1002/alz.12624.


Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation.

Chatterjee P, Tegg M, Pedrini S, Fagan A, Xiong C, Singh A Int J Mol Sci. 2021; 22(6).

PMID: 33805778 PMC: 8000178. DOI: 10.3390/ijms22062931.


References
1.
Melchor J, McVoy L, Van Nostrand W . Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein. J Neurochem. 2000; 74(5):2209-12. DOI: 10.1046/j.1471-4159.2000.0742209.x. View

2.
DeMattos R, Bales K, Cummins D, Paul S, Holtzman D . Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science. 2002; 295(5563):2264-7. DOI: 10.1126/science.1067568. View

3.
Deane R, Wu Z, Sagare A, Davis J, Yan S, Hamm K . LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004; 43(3):333-44. DOI: 10.1016/j.neuron.2004.07.017. View

4.
Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J . Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke. 2002; 33(8):1986-92. DOI: 10.1161/01.str.0000024523.82311.77. View

5.
Wyss-Coray T, Lin C, Sanan D, Mucke L, Masliah E . Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol. 2000; 156(1):139-50. PMC: 1868631. DOI: 10.1016/s0002-9440(10)64713-x. View